Acquisition of Emglev Therapeutics to focus on discovering single-domain antibodies (sdAbs) The VIO-01 trial is currently in Phase 1 dose escalation R&D efforts maintained for optimization ...
Valerio Therapeutics S.A. (Euronext Growth Paris: ALVIO), hereafter "Valerio Therapeutics" or the "Company"), a clinical-stage biotechnology company specializing in the development of innovative drugs ...
A 60-year-old man was cycling along a park connector in Sembawang when he was attacked by hornets. He later died from the ...